GGrantIndex
← Leaderboards

Qiang Gong

Aptitude Medical Systems, Inc.

$6,642,924
Attributed
$6,642,924
Total exposure
8
Grants
8
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.1M · FY201423
$2M$1.5M$1M$500K$0
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$6,642,924 · 8

By mechanism

R44$5,671,816 · 4
R43$971,108 · 4

Top collaborators

No co-investigators on record.

Most similar at Aptitude Medical Systems, Inc.

Same institution · by research overlap

Others in their field

Top investigators on “Performance

Research focus

PerformanceAffinityParticleAptamerCostSmall Business Innovation Research GrantVascular Endothelial Growth FactorsReportingBiologicalCombined Modality TherapyNucleic AcidsBlindnessPharmaceutical PreparationsPre-ClinicalSafetyDoseBindingAngiogenesisIntravitreal InjectionSamplingAptitudeComplementProgramsBase

Grant awards (14)

Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases$755,521
R44 · FY2023 · EY · contact PI
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases$744,393
R44 · FY2022 · EY · contact PI
Targeting SDF-1 for effective wet AMD treatment$805,217
R44 · FY2021 · EY · contact PI
Developing a multivalent agent for long-lasting treatment of diabetic macular edema$224,653
R44 · FY2021 · EY · contact PI
Targeting SDF-1 for effective wet AMD treatment$911,698
R44 · FY2020 · EY · contact PI
Fully modified bispecific aptamer for effective combination therapy of neovascular ocular diseases$224,973
R44 · FY2020 · EY · contact PI
Targeting SDF-1 for effective wet AMD treatment$282,661
R44 · FY2019 · EY · contact PI
Targeting PDGFs for Potential Treatment of Proliferative Vitreoretinopathy$224,946
R43 · FY2019 · EY · contact PI
Topical delivery of therapeutic aptamers$293,239
R43 · FY2018 · EB · contact PI
Targeting SDF-1 for effective wet AMD treatment$250,102
R43 · FY2017 · EY · contact PI
Fully modified bispecific aptamer for effective wet AMD combination treatment$202,821
R43 · FY2017 · EY · contact PI
Particle display: a new paradigm in high throughput discovery of ultra-high perfo$625,303
R44 · FY2016 · GM · contact PI
Particle display: a new paradigm in high throughput discovery of ultra-high perfo$872,697
R44 · FY2015 · GM · contact PI
Particle display: a new paradigm in high throughput discovery of ultra-high perfo$224,700
R44 · FY2014 · GM · contact PI